HOME >> MEDICINE >> NEWS
Controversial drug shown to act on brain protein to cut alcohol use

A naturally occurring hallucinogen advocated by some clinicians as a potent anti-addiction drug has been rigorously studied for the first time, confirming its ability to block alcohol craving in rodents, and clarifying how it works in the brain. The new research findings about the drug Ibogaine open the way for development of other drugs to reverse addiction without Ibogaine's side effects, potentially adding to the small arsenal of drugs that effectively combat addiction.

Derived from a West African shrub, Ibogaine has been championed for years by a cadre of clinicians and drug treatment advocates impressed with its ability to reverse withdrawal symptoms and craving for alcohol and various drugs of abuse. It has been used outside of the U.S. to treat addiction by American and other clinicians. But its side effects, including hallucinations, which made it popular in the 1960s drug culture, and evidence of toxicity to certain nerve cells in rodent studies have discouraged careful studies of its clinical potential against drug and alcohol addiction. The FDA has not approved use of Ibogaine in the U.S.

Scientists at UCSF's Ernest Gallo Clinic and Research Center have now shown definitively in experiments with mice and rats that Ibogaine does reduce alcohol consumption, and they have determined that it does so by increasing the level of a brain protein known as glial cell line-derived neurotrophic factor, or GDNF. In a separate study, they demonstrated that GDNF by itself decreases alcohol consumption.

The research is being published in the January 19 issue of The Journal of Neuroscience.

"By identifying the brain protein that Ibogaine regulates to reduce alcohol consumption in rats, we have established a link between GDNF and reversal of addiction -- knowledge of a molecular mechanism that should allow development of a new class of drugs to treat addiction without Ibogaine's side effects," said Dorit Ron, PhD, UCSF associate professor of
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
18-Jan-2005


Page: 1 2 3

Related medicine news :

1. Controversial Atkins Diet may be beneficial for people with epilepsy
2. Controversial performance enhancer "andro" affects brains as well as brawn, say UMass researchers
3. Cartilage repair techniques shown to restore patient mobility and reduce pain
4. Sprinklers shown effective in slowing dorm fires
5. HPV vaccine shown effective at reducing cancer-causing infections
6. HPV vaccine shown to substantially reduce cervical cancer
7. New research results: Heart jacket shown to be effective
8. Pioglitazone shown to reverse thickening of carotid artery wall
9. Isolated soy protein shown to benefit type 2 diabetics, study indicates
10. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
11. Increased risk of cardiovascular disease shown in PCOS patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2017)... ... April 30, 2017 , ... PracticeMatch, a company that provides healthcare recruiting resources ... year’s physician career fairs, with this year’s RSVPs and registrations so far tracking a ... year of national physician career fairs is located on the PracticeMatch website. ...
(Date:4/29/2017)... , ... April 29, 2017 , ... TransDark is a ... from one video to the next without having to set a single keyframe in ... transitions to enhance your video production. , TransDark features dynamic transitions that momentarily splits ...
(Date:4/29/2017)... ... 2017 , ... Saturday, April 29, marks World Veterinary Day, ... on animal health and welfare as well as on public health. The World ... theme each year and this year have selected “Antimicrobial Resistance—From Awareness to Action,” ...
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... It's ... there are a number of illnesses that are unclear as to whether or not ... their heads. Bronchitis is one of these illnesses. So, FindaTopDoc took a look into ...
(Date:4/28/2017)... LINCOLN, R.I. (PRWEB) , ... April 28, 2017 , ... Getting enough sleep affects much ... Sleep Foundation (NSF), going just 19 hours without sleep can compromise motor reaction time, which ... Awareness Week, and Amica Insurance is sharing the following tips from the NSF to help ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...   ZappRx, Inc ., a digital health company focused ... announced it closed $25 million in Series B funding led ... in Seattle that is part of ... Series B round included participation from SR One , ... GV (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, ... 2024" report to their offering. ... The global pharmacogenomics market was valued at US$ ... 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology:
Cached News: